The Cancer Few Women Are Warned About—and Why Silence Makes It Deadlier
It rarely begins with alarm bells. Instead, it shows up as a lingering itch, a patch of skin that looks different, or discomfort that’s easy to explain away.
Many women notice these changes and decide to wait—telling themselves it’s nothing serious, something that will pass. Too often, that hesitation is exactly what allows a dangerous disease to advance unnoticed.
Vulval cancer remains one of the least talked-about cancers in women’s health, not because it is untreatable, but because it exists in a space many feel uncomfortable discussing.
There is no routine screening program for vulval cancer, and conversations about symptoms affecting intimate areas are frequently avoided—by patients and, at times, even by healthcare providers. As a result, diagnosis is often delayed until the disease has progressed.

Although vulval cancer is considered rare, it is far from insignificant. Hundreds of women die from it each year, and many more undergo extensive treatment that might have been avoided with earlier detection.
The problem isn’t a lack of medical knowledge—it’s a lack of awareness and openness. Symptoms are often mistaken for common skin conditions, menopausal changes, or infections. In some cases, women are reassured without further investigation, losing valuable time.
Vulval cancer can develop on the inner or outer labia, around the clitoris, or near the vaginal opening. It is most commonly diagnosed in women over the age of 65, but rates among younger women have been rising. Risk factors include certain types of human papillomavirus (HPV) and long-term inflammatory skin conditions such as lichen sclerosus.
Warning signs may include a persistent lump or sore, thickened or discolored skin, wart-like growths, unexplained bleeding, burning or itching that does not resolve, and pain during urination or sex. These symptoms are not a normal part of aging, hormonal change, or stress—and they should never be ignored.
When vulval cancer is found early, treatment is often straightforward and highly effective, sometimes involving only minor surgery. Later-stage diagnoses, however, can require aggressive procedures that significantly affect quality of life. The difference between these outcomes often comes down to how quickly concerns are taken seriously.
Breaking this pattern starts with normalizing conversations about intimate health. Women should feel empowered to speak openly, trust their instincts, and seek further evaluation if symptoms persist—even if initial reassurance doesn’t feel right. No concern is too small when it comes to unexplained changes in the body.
Conclusion
Vulval cancer thrives in silence, not because it is invisible, but because it is rarely discussed. Awareness, early action, and honest conversations can dramatically change outcomes. Paying attention to symptoms and refusing to dismiss discomfort isn’t overreacting—it’s self-protection. When women’s health concerns are spoken aloud and taken seriously, lives are saved.